comparemela.com

Latest Breaking News On - Scancell holdings - Page 18 : comparemela.com

Positive Trial Response brings COVIDITY Candidate into Development Arena

Cancer and infectious disease immunotherapies developer Scancell Holdings (Oxford, UK), has announced preliminary immunogenicity data from its Phase 1 COVIDITY clinical trial. Click to read more.

Scancell looking to partner after positive COVID vaccine data

Scancell has announced immunogenicity data from its phase 1 COVIDITY clinical trial at the University of Cape Town Lung Institute. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.